Who is sponsoring NCT04633837?

NCT04633837 is sponsored by Brian Badman.

What drugs are being tested in NCT04633837?

Interventions in NCT04633837: Extracellular Matrix Graft Injectable Implant.

What condition does NCT04633837 study?

NCT04633837 studies Arthroscopic Shoulder Surgery, Pain, Postoperative.

Is NCT04633837 still recruiting?

NCT04633837 is currently terminated. Last updated 6 January 2022.

Are results published for NCT04633837?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2022-01-06 · How we verify

NCT04633837: ECM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Examining the Effectiveness of a Connective Tissue Matrix Implant in Reducing Post-operative Pain and Narcotic After Outpatient Arthroscopic Shoulder Surgery

Terminated NA Results posted Last updated 6 January 2022

What this trial tests

NA trial testing Extracellular Matrix Graft Injectable Implant in Arthroscopic Shoulder Surgery in 15 participants. Terminated before completion.

Timeline

4 December 2020

Primary endpoint
7 November 2021

7 November 2021

Quick facts

Lead sponsor	Brian Badman
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	15
Start date	4 December 2020
Primary completion	7 November 2021
Estimated completion	7 November 2021
Sites	1 location across United States

Drugs / interventions tested

Extracellular Matrix Graft Injectable Implant

Conditions studied

Arthroscopic Shoulder Surgery — all drugs for Arthroscopic Shoulder Surgery →
Pain, Postoperative — all drugs for Pain, Postoperative →

Sponsor

Brian Badman

Who can join

Adults 18 to 55, any sex, with Arthroscopic Shoulder Surgery or Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This document is a protocol for a human research study. This study is to be conducted according to United States standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. Extracellular matrix grafts have been used to help with postoperative inflammation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Arthroscopic Shoulder Surgery

Currently open trials in the same condition.

NCT07429669 — Comparative Analgesia and Respiratory Effects of Shoulder Blocks · NA · recruiting
NCT07253740 — Interscalene Versus Infraspinatus-Teres Minor Blocks for Arthroscopic Shoulder Surgery · NA · recruiting
NCT07090733 — Ultrasound Guided Interscalene, Suprascapular and Anterior Glenoid Nerve Blocks on Diaphragmatic Excursion and Analgesia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04633837 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brian Badman
Last refreshed: 6 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04633837.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing